ARCHIVES

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Lapatinib For Advanced Breast Cancer

March 30, 2007

NCCAM Trial Tests Electroacupuncture for Delayed Nausea.

June 14, 2002

Democrats Say Bush Budget Neglects NSF And NASA.

March 23, 2001

Ford Gets Temporary Funds Bill; House Committee Demands More Positions for NCI

June 27, 1975

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

November 6, 1998

Study Sheds Light On How NSAIDS Prevent Colon Cancer

April 25, 2003